Andreas L Birkenfeld
Overview
Explore the profile of Andreas L Birkenfeld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
263
Citations
6474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wagner R, Buettner J, Heni M, Fritsche L, Kullmann S, Wagmuller M, et al.
BMC Med
. 2024 Nov;
22(1):558.
PMID: 39593091
Background: The potential impact of specific food additives, common in Western diets, on the risk of developing type 2 diabetes is not well understood. This study focuses on carrageenan, a...
12.
Sommer J, Borgmann S, Gontscharuk V, Zaharia O, Maalmi H, Herder C, et al.
Lancet Diabetes Endocrinol
. 2024 Nov;
12(12):890-903.
PMID: 39491874
Background: The subjective experiences of individuals living with diabetes is commonly assessed with patient-reported outcomes (PROs; eg, depression symptoms, wellbeing, health-related quality of life [HRQOL], and diabetes-related distress). Cluster analyses...
13.
Inau E, Dedie A, Anastasova I, Schick R, Zdravomyslov Y, Frohlich B, et al.
Sci Data
. 2024 Oct;
11(1):1159.
PMID: 39433782
The German Center for Diabetes Research (DZD) established a core data set (CDS) of clinical parameters relevant for diabetes research in 2021. The CDS is central to the design of...
14.
Linge J, Birkenfeld A, Neeland I
Circulation
. 2024 Oct;
150(16):1288-1298.
PMID: 39401279
Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and combination therapies is approaching magnitudes achieved with surgery. However, as more weight loss is...
15.
Didangelos T, Karlafti E, Kotzakioulafi E, Giannoulaki P, Kontoninas Z, Kontana A, et al.
Nutrients
. 2024 Sep;
16(18).
PMID: 39339645
Aim: To investigate the efficacy of Palmitoylethanolamide (PEA, 300 mg), Superoxide Dismutase (SOD, 70 UI), Alpha Lipoic Acid (ALA, 300 mg), vitamins B6 (1.5 mg), B1 (1.1 mg), B12 (2.5...
16.
Gill D, Dib M, Gill R, Bornstein S, Burgess S, Birkenfeld A
Genes (Basel)
. 2024 Aug;
15(8).
PMID: 39202419
Adenosine triphosphate-citrate lyase (ACLY) inhibition has proven clinically efficacious for low-density lipoprotein cholesterol (LDL-c) lowering and cardiovascular disease (CVD) risk reduction. Clinical and genetic evidence suggests that some LDL-c lowering...
17.
Zhao S, Semeia L, Veit R, Luo S, Angelo B, Chow T, et al.
Int J Obes (Lond)
. 2024 Aug;
48(12):1728-1734.
PMID: 39198584
Objectives: Intrauterine exposure to gestational diabetes mellitus (GDM) increases the risk of obesity in the offspring, but little is known about the underlying neural mechanisms. The hippocampus is crucial for...
18.
Stefan N, Schiborn C, Machann J, Birkenfeld A, Schulze M
Lancet Diabetes Endocrinol
. 2024 Jul;
12(8):514-515.
PMID: 38968941
No abstract available.
19.
Sancar G, Birkenfeld A
J Endocrinol
. 2024 Jul;
262(3).
PMID: 38967989
The root cause of type 2 diabetes (T2D) is insulin resistance (IR), defined by the failure of cells to respond to circulating insulin to maintain lipid and glucose homeostasis. While...
20.
Neeland I, Linge J, Birkenfeld A
Diabetes Obes Metab
. 2024 Jun;
26 Suppl 4:16-27.
PMID: 38937282
Weight loss induced by glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dual glucagon-like peptide-1 receptor (GLP-1R)/glucose-dependent insulinotropic polypeptide receptor agonists is coming closer to the magnitudes achieved with surgery. However, with...